BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 19651633)

  • 21. Flow-cytometric analysis of growth-regulatory peptides and their receptors in Barrett's oesophagus and oesophageal adenocarcinoma.
    Jankowski J; Hopwood D; Wormsley KG
    Scand J Gastroenterol; 1992; 27(2):147-54. PubMed ID: 1348589
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Activation of Akt is increased in the dysplasia-carcinoma sequence in Barrett's oesophagus and contributes to increased proliferation and inhibition of apoptosis: a histopathological and functional study.
    Beales IL; Ogunwobi O; Cameron E; El-Amin K; Mutungi G; Wilkinson M
    BMC Cancer; 2007 Jun; 7():97. PubMed ID: 17559672
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Expression profiles of cancer stem cell markers: CD133, CD44, Musashi-1 and EpCAM in the cardiac mucosa-Barrett's esophagus-early esophageal adenocarcinoma-advanced esophageal adenocarcinoma sequence.
    Mokrowiecka A; Veits L; Falkeis C; Musial J; Kordek R; Lochowski M; Kozak J; Wierzchniewska-Lawska A; Vieth M; Malecka-Panas E
    Pathol Res Pract; 2017 Mar; 213(3):205-209. PubMed ID: 28216140
    [TBL] [Abstract][Full Text] [Related]  

  • 24. K-ras point mutations are rare events in premalignant forms of Barrett's oesophagus.
    Trautmann B; Wittekind C; Strobel D; Meixner H; Keymling J; Gossner L; Ell C; Hahn EG
    Eur J Gastroenterol Hepatol; 1996 Aug; 8(8):799-804. PubMed ID: 8864678
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Past, present and future of Barrett's oesophagus.
    Tan WK; di Pietro M; Fitzgerald RC
    Eur J Surg Oncol; 2017 Jul; 43(7):1148-1160. PubMed ID: 28256346
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Genome-wide association studies in oesophageal adenocarcinoma and Barrett's oesophagus: a large-scale meta-analysis.
    Gharahkhani P; Fitzgerald RC; Vaughan TL; Palles C; Gockel I; Tomlinson I; Buas MF; May A; Gerges C; Anders M; Becker J; Kreuser N; Noder T; Venerito M; Veits L; Schmidt T; Manner H; Schmidt C; Hess T; Böhmer AC; Izbicki JR; Hölscher AH; Lang H; Lorenz D; Schumacher B; Hackelsberger A; Mayershofer R; Pech O; Vashist Y; Ott K; Vieth M; Weismüller J; Nöthen MM; ; ; ; Attwood S; Barr H; Chegwidden L; de Caestecker J; Harrison R; Love SB; MacDonald D; Moayyedi P; Prenen H; Watson RGP; Iyer PG; Anderson LA; Bernstein L; Chow WH; Hardie LJ; Lagergren J; Liu G; Risch HA; Wu AH; Ye W; Bird NC; Shaheen NJ; Gammon MD; Corley DA; Caldas C; Moebus S; Knapp M; Peters WHM; Neuhaus H; Rösch T; Ell C; MacGregor S; Pharoah P; Whiteman DC; Jankowski J; Schumacher J
    Lancet Oncol; 2016 Oct; 17(10):1363-1373. PubMed ID: 27527254
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mucin gene expression and cell differentiation in human normal, premalignant and malignant esophagus.
    Guillem P; Billeret V; Buisine MP; Flejou JF; Lecomte-Houcke M; Degand P; Aubert JP; Triboulet JP; Porchet N
    Int J Cancer; 2000 Dec; 88(6):856-61. PubMed ID: 11093805
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Expression of CD44 in premalignant and malignant Barrett's oesophagus.
    Lagorce-Pages C; Paraf F; Dubois S; Belghiti J; Fléjou JF
    Histopathology; 1998 Jan; 32(1):7-14. PubMed ID: 9522210
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Time gated fluorescence spectroscopy in Barrett's oesophagus.
    Ortner MA; Ebert B; Hein E; Zumbusch K; Nolte D; Sukowski U; Weber-Eibel J; Fleige B; Dietel M; Stolte M; Oberhuber G; Porschen R; Klump B; Hörtnagl H; Lochs H; Rinneberg H
    Gut; 2003 Jan; 52(1):28-33. PubMed ID: 12477755
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Patterns of p53 immunoreactivity in non-neoplastic and neoplastic Barrett's mucosa of the oesophagus: in-depth evaluation in endoscopic mucosal resections.
    Toon C; Allanson B; Leslie C; Acott N; Mirzai B; Raftopoulos S; Kumarasinghe MP
    Pathology; 2019 Apr; 51(3):253-260. PubMed ID: 30826014
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Abnormal expression of growth regulatory factors in Barrett's oesophagus.
    Jankowski J; McMenemin R; Hopwood D; Penston J; Wormsley KG
    Clin Sci (Lond); 1991 Nov; 81(5):663-8. PubMed ID: 1661653
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Differential SPARC mRNA expression in Barrett's oesophagus.
    Brabender J; Lord RV; Metzger R; Park J; Salonga D; Danenberg KD; Danenberg PV; Hölscher AH; Schneider PM
    Br J Cancer; 2003 Oct; 89(8):1508-12. PubMed ID: 14562024
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The phenotype of gastric mucosa coexisting with Barrett's oesophagus.
    Rugge M; Russo V; Busatto G; Genta RM; Di Mario F; Farinati F; Graham DY
    J Clin Pathol; 2001 Jun; 54(6):456-60. PubMed ID: 11376019
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The expression of 8-hydroxydeoxyguanosine in oesophageal tissues and tumours.
    Räsänen JV; Sihvo EI; Ahotupa MO; Färkkilä MA; Salo JA
    Eur J Surg Oncol; 2007 Dec; 33(10):1164-8. PubMed ID: 17467227
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Transcriptional analyses of Barrett's metaplasia and normal upper GI mucosae.
    Barrett MT; Yeung KY; Ruzzo WL; Hsu L; Blount PL; Sullivan R; Zarbl H; Delrow J; Rabinovitch PS; Reid BJ
    Neoplasia; 2002; 4(2):121-8. PubMed ID: 11896567
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pericentriolar material analyses in normal esophageal mucosa, Barrett's metaplasia and adenocarcinoma.
    Segat D; Cassaro M; Dazzo E; Cavallini L; Romualdi C; Salvador R; Vitale MP; Vitiello L; Fassan M; Rugge M; Zaninotto G; Ancona E; Baroni MD
    Histol Histopathol; 2010 May; 25(5):551-60. PubMed ID: 20238294
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Expression of the p53 homologue p63alpha and DeltaNp63alpha in the neoplastic sequence of Barrett's oesophagus: correlation with morphology and p53 protein.
    Hall PA; Woodman AC; Campbell SJ; Shepherd NA
    Gut; 2001 Nov; 49(5):618-23. PubMed ID: 11600462
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A family history of Barrett's oesophagus: another risk factor?
    Groves C; Jankowski J; Barker F; Holdstock G
    Scand J Gastroenterol; 2005 Sep; 40(9):1127-8. PubMed ID: 16211720
    [TBL] [Abstract][Full Text] [Related]  

  • 39. CagA in Barrett's oesophagus in Colombia, a country with a high prevalence of gastric cancer.
    Kudo M; Gutierrez O; El-Zimaity HM; Cardona H; Nurgalieva ZZ; Wu J; Graham DY
    J Clin Pathol; 2005 Mar; 58(3):259-62. PubMed ID: 15735156
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Barrett's oesophagus: from metaplasia to dysplasia and cancer.
    Fléjou JF
    Gut; 2005 Mar; 54 Suppl 1(Suppl 1):i6-12. PubMed ID: 15711008
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.